Hyperleukocytosis in childhood acute lymphoblastic leukemia: Complications and treatment outcome

Turkish Journal of Hematology

Volumn 23, Issue 3, 2006, Pages 142-146

  Irken, Gülersu ^a   Ören, Hale ^a   Öniz, Haldun ^b   Çetingül, Nazan ^c   Vergin, Canan ^d   Atabay, Berna ^b   Gülen, Hüseyin ^d   Türker, Meral ^b   Kantar, Mehmet ^c   Yilmaz, Şebnem ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b SSK Tepecik Teaching Hospital   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

Hyperleukocytosis; Lymphoblastic leukemia; Survival

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; CALCIUM; PHOSPHATE; URIC ACID;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALKALINIZATION; ARTICLE; BLOOD CLOTTING DISORDER; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CERVICAL LYMPHADENOPATHY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HYDRATION; HYPERCALCEMIA; HYPERLEUKOCYTOSIS; HYPERPHOSPHATEMIA; HYPERURICEMIA; KAPLAN MEIER METHOD; LABORATORY TEST; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; MEDIASTINUM MASS; METABOLIC DISORDER; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PROGNOSIS; RESPIRATORY DISTRESS; SEPSIS; TREATMENT OUTCOME;

EID: 33846165400     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wald BR, Heisel MA, Ortega JA. Frequency of early death in children with acute leukemia presenting with hyperleukocytosis. Cancer 1982;50:150-3.
2. Eguiguren JM, Schnell MJ, Crist WM, Kunkel K, Rivera GK. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992;79:871-5.
3. Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A, Lukens J, Siegel S. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 1989;14:124-34.
4. Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC. Heterogeneity and prognostic features among 120 children with T-cell acute lymphoblastic leukemia. Blood 1990;75:174-9.
5. Dearth JC, Fountain KS, Smithson WA, Burgert EO Jr, Gilchrist GS. Extreme leukemic leukocytosis in childhood. Mayo Clin Proc 1978;53:207-11.
6. Dearth J, Salter M, Wilson E, Kelly D, Crist W. Early death in acute leukemia in children. Med Pediatr Oncol 1983;11:225-8.
7. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002;6:15-23.
8. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, Gadner H, Odenwald E, Riehm H. Long - term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000;14:2205-22.
9. Nelson SC, Bruggers CS, Kurtzberg J, Friedman HS. Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol 1993;15:351-5.
10. Lascari AD. Improvement of leukemic hyperleukocytosis with only fluid and allopurinol therapy. Am J Dis Child 1991;145:969-70.
11. Maurer HS, Steinherz PG, Gaynon PS, Finklestein JZ, Sather HN, Reaman GH, Bleyer WA, Hammond GD. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol 1988;6:1425-32.
12. Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr Oncol 1987;15:232-5.
13. Strauss RA, Gloster ES, McCallister JA, Jimenez JF, Neuberg RW, Berry DH. Acute cytoreduction techniques in the early treatment of hyperleukocytosis associated with childhood hematologic malignancies. Med Pediatr Oncol 1985;13:346-51.
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. French-American-British (FAB) Co-operative Group. Br J Haematol 1976;33:451-8.
15. Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, Bleyer WA. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000;14:2223-33.
16. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA. Long term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia 2000;14:2276-85.
17. Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Engl J Med 1986;315:657-63.
18. Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Lipton JM, Cohen HJ, Sallan SE. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000;14:2247-56.
19. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J Jr, Ochs JS, Look AT, Williams DL. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991;337:61-6.
20. Conter V, Arico M, Valsecchi MG, Basso G, Biondi A, Madon E, Mandelli F, Paolucci G, Pession A, Rizzari C, Rondelli R, Zanesco L, Masera G. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia 2000;14:2196-204.
21. Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM, Hann IM, Hill FG, Gibson BE. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia 2000;14:2307-20.